Avalo Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | 546.2 | 12.2 | 19.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.2 | – | – | – | – | – | |
| – | – | – | 1,083.9 | 1,735.8 | 282.4 | 4.5 | 4.0 | 4.2 | 6.1 | 16.7 | 16.3 | 9.3 | 46.8 | 38.0 | 183.0 | – | 31.5 | 64.4 | 55.7 | 33.1 | 36.0 | 13.5 | 14.9 | 1.8 | 2.6 | 1.2 | 0.3 | 2.5 | 3.8 | 12.9 | 118.5 | 124.9 | 175.7 | 190.7 | 122.8 | 926.1 | 5,710.7 | 5,077.9 | 13,671.8 | |
| 819.8 | 15,041.0 | 9,453.6 | – | 578.8 | 328.9 | 5.5 | 7.2 | 8.3 | 5.3 | 13.9 | 17.4 | 10.4 | 15.0 | 6.1 | 3.6 | 4.8 | 8.6 | 8.6 | 16.6 | 5.5 | 8.4 | 13.0 | – | – | – | – | – | 0.4 | 1.0 | – | – | 4.9 | 0.6 | 0.7 | 0.5 | 1.9 | 4.1 | 4.4 | 1.8 | |
| – | – | – | 1,082.9 | 1,731.1 | – | 4.4 | 4.0 | 4.1 | 5.5 | 16.0 | 15.9 | 9.1 | 46.2 | – | 137.2 | – | 28.8 | 55.8 | 52.1 | 27.3 | 32.0 | 12.7 | 17.1 | 1.9 | 3.0 | 1.4 | 0.8 | -1.8 | 0.2 | -62.7 | 3.5 | 25.8 | -128.1 | -91.6 | 28.0 | 787.9 | 5,448.6 | 4,659.9 | 12,228.8 | |
| – | – | – | – | – | – | 8.6 | 9.2 | 12.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.2 | -0.7 | -0.6 | – | – | – | – | – | |
| – | – | – | – | – | 639.4 | 9.1 | 8.3 | 9.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.7% | -0.4% | -0.7% | -0.8% | -0.6% | 0.2% | 11.0% | 12.1% | 11.0% | -3.3% | -2.1% | -4.3% | -10.6% | -6.1% | -14.0% | -13.1% | -14.9% | -19.2% | -18.7% | -17.8% | -30.9% | -36.6% | -83.5% | -110.1% | -128.8% | -57.1% | -99.0% | -385.4% | -568.6% | -422.7% | -144.1% | -33.7% | -36.1% | -63.3% | -62.2% | -87.6% | -29.4% | -15.3% | -19.9% | -8.2% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | -354.6% | -401.9% | 93.3% | 92.8% | 91.1% | 84.5% | 59.2% | 55.5% | 45.3% | 57.6% | 58.6% | 77.8% | 327.1% | – | -61.7% | -145.4% | -222.0% | -222.9% | -265.1% | -233.7% | -216.7% | 33.4% | 81.0% | 55.6% | 59.7% | -191.2% | -196.6% | 53.0% | 60.8% | 177.8% | 174.8% | -1,176.2% | -3,515.6% | -13,779.7% | -44,920.3% | -34,928.8% | – | |
| – | – | – | -847.5% | -1,083.1% | 64.3% | 49.1% | 31.7% | -30.1% | -214.5% | -222.5% | -227.7% | -110.3% | -239.1% | -990.2% | -4,724.0% | – | -1,930.6% | -2,908.2% | -2,226.2% | -2,194.2% | -1,696.9% | -1,342.5% | -1,777.7% | -267.9% | -207.4% | -146.3% | -122.0% | -1,268.8% | -1,217.8% | -1,371.0% | -2,763.9% | -3,831.2% | -9,291.6% | -11,432.2% | -13,641.0% | -34,632.3% | -123,601.7% | -134,164.4% | -154,844.1% | |
| – | – | – | -864.2% | -1,106.3% | 51.7% | 36.9% | 20.4% | -41.1% | -218.5% | -226.6% | -231.7% | -113.7% | -238.1% | -726.5% | -3,748.7% | – | -947.8% | -1,653.4% | -1,194.6% | -1,210.8% | -1,563.4% | -1,242.4% | -1,897.5% | -293.8% | -230.8% | -170.4% | -146.0% | -1,475.0% | -1,638.6% | -9,853.7% | -4,488.6% | -970.5% | -7,965.8% | 16,556.0% | -10,479.8% | -52,019.8% | -132,642.4% | -143,627.1% | -170,055.9% | |
| – | – | – | -854.2% | -1,067.6% | 44.2% | 49.2% | 48.5% | 46.6% | -20.1% | -34.7% | -69.5% | -98.7% | -287.3% | -533.8% | -2,403.8% | – | -606.0% | -1,203.9% | -991.8% | -1,022.8% | -1,315.6% | -1,127.4% | -1,644.3% | -230.3% | -149.0% | -120.4% | -114.3% | -1,418.2% | -1,602.0% | -1,861.2% | -3,995.7% | -4,504.4% | -11,123.8% | -11,861.9% | -10,752.4% | -27,216.7% | -87,216.9% | -101,172.9% | -112,505.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -233.4% | -3,149.3% | -7,957.4% | – | -368.9% | 60.2% | 45.1% | 36.6% | -80.9% | -191.6% | -188.7% | -247.7% | -127.6% | -76.6% | -116.2% | -72.7% | -119.9% | -258.5% | -220.4% | -356.2% | -200.5% | -365.5% | -1,194.2% | – | – | – | – | – | -225.8% | -431.9% | – | – | -37.8% | -26.4% | 59.5% | -44.2% | -109.1% | -94.2% | -124.0% | -22.4% | |
| -98.7% | -192.9% | -285.5% | -373.3% | -191.3% | 47.2% | 16.9% | 11.3% | -23.3% | -57.0% | -58.3% | -73.5% | -40.7% | -44.5% | -67.4% | -53.2% | -78.1% | -145.1% | -115.3% | -120.0% | -84.8% | -105.2% | -122.4% | -222.3% | -139.7% | -124.8% | -81.6% | -102.2% | -113.4% | -150.3% | -115.5% | -33.4% | -8.1% | -23.3% | 52.7% | -36.5% | -79.8% | -67.2% | -84.8% | -20.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -8.5 | -5.6 | -2.8 | -1.5 | -4.9 | – | -1.7 | -1.1 | -5.8 | -9.6 | -15 | -8.3 | -4.1 | -3.5 | – | -45 | -33 | -18 | -38 | -23 | -39 | -21 | -4.8 | 8.0 | 2.6 | 6.8 | 3.6 | 8.3 | -9.6 | -6.9 | -110 | -93 | -81 | -134 | -125 | -42 | -27 | -15 | -25 | -85 | |
| – | – | – | – | – | – | -0.1 | -0.1 | -0.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.1 | -0.8 | -1.6 | -1.7 | – | – | – | – | – | |
| 42.3% | 6.1% | 3.6% | -12.0% | 51.8% | 78.4% | 37.6% | 30.9% | 28.9% | 29.8% | 30.9% | 29.7% | 31.9% | 58.1% | 58.0% | 73.1% | 65.2% | 56.1% | 52.3% | 33.7% | 42.3% | 28.8% | 10.2% | -18.5% | -5.5% | -32.7% | -17.3% | -28.8% | 50.2% | 34.8% | -81.7% | -12.6% | 21.4% | 88.3% | 88.5% | 82.6% | 73.2% | 71.3% | 68.4% | 91.4% | |
| 0.6 | 5.4 | 11.4 | – | 0.2 | – | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.8 | 1.4 | 5.3 | – | – | – | – | – | 0.0 | 0.1 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -18.04 | -25.33 | -21.33 | -15.61 | -10.46 | 4.48 | 1,018.82 | 628.06 | -1,311.05 | -3,329.13 | -2,260.90 | -2,211.67 | -1,164.02 | -792.02 | -1,376.39 | -1,533.63 | -1,640.15 | -2,250.18 | -2,218.13 | -2,038.74 | -2,316.31 | -2,129.15 | -1,934.05 | -1,828.67 | -1,301.30 | -1,061.35 | -605.22 | -425.45 | -170.33 | -39.34 | -166.26 | -4.73 | -0.74 | -3.35 | 6.94 | -4.27 | -7.13 | -4.23 | -4.21 | -2.30 | |
| – | – | – | 1.81 | 0.95 | 8.67 | 2,764.61 | 3,078.18 | 3,190.12 | 1,523.30 | 997.95 | 954.48 | 1,024.14 | 332.64 | 189.45 | 40.91 | -124.89 | 237.42 | 134.16 | 170.66 | 191.30 | 136.19 | 155.67 | 96.37 | 442.94 | 459.90 | 355.27 | 291.38 | 11.55 | 2.40 | 1.69 | 0.11 | 0.08 | 0.04 | 0.04 | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 | |
| 7.73 | 0.80 | 0.27 | -0.50 | 2.84 | 7.44 | 2,260.71 | 1,716.63 | 1,621.47 | 1,737.82 | 1,198.27 | 892.76 | 912.16 | 1,034.62 | 1,184.44 | 2,108.21 | 1,368.11 | 870.38 | 1,006.56 | 572.43 | 1,155.22 | 582.45 | 161.96 | -151.93 | -51.70 | -278.09 | -128.30 | -119.71 | 75.42 | 9.11 | -117.63 | -1.78 | 1.95 | 12.70 | 11.66 | 9.66 | 6.54 | 4.49 | 3.40 | 10.29 | |
| -45.52 | -47.17 | -18.92 | -15.43 | -10.10 | 3.83 | 1,361.24 | 1,492.42 | 1,486.48 | -306.92 | -346.22 | -663.32 | -1,010.76 | -955.81 | -1,011.29 | -983.44 | -989.94 | -1,438.76 | -1,615.10 | -1,692.59 | -1,956.57 | -1,791.74 | -1,755.01 | -1,584.73 | -1,020.19 | -685.40 | -427.62 | -333.02 | -163.77 | -38.46 | -31.40 | -4.21 | -3.43 | -4.68 | -4.97 | -4.38 | -3.73 | -2.78 | -2.97 | -1.52 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.